On 5/13/24, Emergent BioSolutions Inc (NYSE: EBS) stock enjoyed a major increase of 23.2%, closing at $5.36. Trading volume in this advance was normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 37.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Emergent BioSolutions has a good Appreciation Score of 82 but a very low Power Rating of 6, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment